In January 2019, the US Food & Drug Administration (FDA) made an unprecedented call for an OTC Naloxone product. Why? Because every 8 minutes someone in America is dying from an opioid overdose – and the antidote Naloxone is not at hand to save them.
But it could be.
Pocket Naloxone is answering that call for OTC Naloxone to remove the critical barriers that exist:
More than 35 million people (yes, that’s 10 percent of the population) are at risk of an opioid overdose and desperately need an accessible, affordable antidote. There is an urgent need, and we are proud to play a role in addressing this aspect of the opioid crisis to limit needless overdose deaths.